Search Within

Charles Rudin

  1. "Biostatistics Service"
Formats
  1. Journal Article (62)
  2. Meeting Abstract (38)
  3. Research Letter (2)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (102)
  2. Biostatistics Service (102)
  3. Department of Medicine (102)
  4. Epidemiology and Biostatistics (102)
  5. GSK Faculty (102)
  6. Solid Tumor Oncology Division (102)

More Groups

People
  1. Mark Kris (48)
  2. Gregory Riely (42)
  3. Bob Li (41)
  4. Marc Ladanyi (41)
  5. Maria Arcila (40)
  6. Matthew Hellmann (38)

More People

Years
  1. 2025 (2)
  2. 2024 (8)
  3. 2023 (10)
  4. 2022 (8)
  5. 2021 (9)
  6. 2020 (14)

More Years

Publications
  1. Journal of Clinical Oncology (21)
  2. Clinical Cancer Research (14)
  3. Journal of Thoracic Oncology (12)
  4. Annals of Oncology (6)
  5. International Journal of Radiation Oncology, Biology, Physics (6)
  6. Cancer Cell (4)

More Publications

Publishers
  1. American Society of Clinical Oncology (24)
  2. Elsevier Inc. (24)
  3. American Association for Cancer Research (18)
  4. Oxford University Press (8)
  5. Cell Press (7)
  6. Nature Publishing Group (6)

More Publishers

Results (102)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Next-generation sequencing for HLA genotype screening and matching to HLA-restricted therapies
    Research Letter

    Gormally, M. V.; Chen, M. F.; Noronha, A. M.; Panageas, K.; Reynolds, M.; Kohlasch, K.; Novak, B.; Kee-Velez, T.; Clarke, N.; Eubank, M.; more...
    JAMA Oncology (2025)

    Fulltext@MSK | Save
  • Brief report: Clinical characteristics and outcomes of patients with thoracic SMARCA4-deficient undifferentiated tumors
    Journal Article

    Cooper, A. J.; Arfe, A.; Ricciuti, B.; Gagné, A.; Sholl, L. M.; Di Federico, A.; Awad, M. M.; Aldea, M.; Ghigna, M. R.; Grecea, M.; more...
    JTO Clinical and Research Reports (2025)

    Fulltext@MSK | Save
  • Persistence and resistance of HER2 amplification after T-DM1 in a basket trial for patients with solid tumors
    Meeting Abstract

    Liu, D.; Arora, K.; Makker, V.; Buonocore, D.; Shen, R.; Yaeger, R.; Ginsberg, M. S.; Yeh, R.; Offin, M. D.; Solit, D.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Automated real-world data integration improves cancer outcome prediction
    Journal Article

    Jee, J.; Fong, C.; Pichotta, K.; Tran, T. N.; Luthra, A.; Waters, M.; Fu, C.; Altoe, M.; Liu, S. Y.; Maron, S. B.; more...
    Nature (2024)

    Fulltext@MSK | Save
  • Intratumoral escherichia is associated with improved survival to single-agent immune checkpoint inhibition in patients with advanced non–small-cell lung cancer
    Journal Article

    Elkrief, A.; Montesion, M.; Sivakumar, S.; Hale, C.; Bowman, A. S.; Begüm Bektaş, A.; Bradic, M.; Kang, W.; Chan, E.; Gogia, P.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A phase I/II study of valemetostat (DS-3201b), an EZH1/2 inhibitor, in combination with irinotecan in patients with recurrent small-cell lung cancer
    Journal Article

    Choudhury, N. J.; Lai, W. V.; Makhnin, A.; Heller, G.; Eng, J.; Li, B.; Preeshagul, I.; Santini, F. C.; Offin, M.; Ng, K.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Optimal systemic treatment and real-world clinical application of ctDNA in patients with metastatic HER2-mutant lung cancer
    Journal Article

    Liu, S. Y.; Erazo, T.; Jee, J.; Arfe, A.; Gupta, A.; Pike, L. R. G.; Santini, F. C.; Daly, B.; Schoenfeld, A.; Eichholz, J.; more...
    European Journal of Cancer (2024)

    Fulltext@MSK | Save
  • Imaging with [(89)Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: A phase 1/2, first-in-human trial
    Journal Article

    Tendler, S.; Dunphy, M. P.; Agee, M.; O'Donoghue, J.; Aly, R. G.; Choudhury, N. J.; Kesner, A.; Kirov, A.; Mauguen, A.; Baine, M. K.; more...
    Lancet Oncology (2024)

    Fulltext@MSK | Save
  • Biomarkers associated with pulmonary exacerbations in a randomized trial of nintedanib for radiation pneumonitis
    Journal Article

    Moore, Z. R.; Huang, X.; Lobaugh, S.; Zhang, Z.; Wong, P.; Geyer, A.; Pagano, A.; Rudin, C. M.; Jones, D. R.; Gomez, D. R.; more...
    Radiotherapy and Oncology (2024)

    Fulltext@MSK | Save
  • Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): An open-label, randomised, controlled, phase 2 study
    Journal Article

    Tsai, C. J.; Yang, J. T.; Shaverdian, N.; Patel, J.; Shepherd, A. F.; Eng, J.; Guttmann, D.; Yeh, R.; Gelblum, D. Y.; Namakydoust, A.; more...
    Lancet (2024)

    Fulltext@MSK | Save